← Back to Search

Exercise Training for Cognitive Impairment in Multiple Sclerosis

N/A
Waitlist Available
Led By Brian M Sandroff, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must not be actively engaging in cognitive rehabilitation, or participating in regular brain fitness activities
Participants must be between the ages of 18-65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if treadmill walking can help improve cognitive processing speed for people with MS.

Who is the study for?
This trial is for people aged 18-65 with a definite MS diagnosis, an EDSS score of 0-4.0, and slowed cognitive processing speed. Participants must be relapse-free for at least 30 days, right-handed, have decent vision and mental state scores, stable on MS therapy for six months, and not have MRI contraindications.
What is being tested?
The study compares the effects of a supervised treadmill walking exercise program against stretching-and-toning exercises on cognitive speed and brain function in those with MS-related cognitive impairments over three months.
What are the potential side effects?
While specific side effects are not listed for this type of physical intervention study, participants may experience general exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not currently in cognitive rehabilitation or doing regular brain exercises.
Select...
I am between 18 and 65 years old.
Select...
I haven't taken corticosteroids or had a relapse in the last 30 days.
Select...
I have never been diagnosed with major depression, schizophrenia, bipolar disorder, or substance-abuse disorders.
Select...
I am not taking any medications that can affect my thinking.
Select...
I can walk without assistance, based on my EDSS score.
Select...
My mental state is clear enough for decision making.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognitive Processing Speed
Thalamocortical Resting State Functional Connectivity Region 2
Thalamocortical Resting-State Functional Connectivity Region 1

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treadmill Walking Exercise TrainingExperimental Treatment1 Intervention
This condition will include 3-months of supervised, progressive light, moderate, and vigorous intensity treadmill walking exercise training based on ACSM guidelines for maximizing adaptations with exercise training. Exercise intensities will be prescribed based on percent oxygen consumption reserve (% VO2R) using values derived from the baseline graded exercise test. The exercise training itself will be led by trained exercise leaders who are not involved in the collection of outcome assessments. At the outset of each session, participants will be fitted with a Polar HR Monitor (Oy, Finland), and HR will be monitored continuously throughout each session. Each session will begin with a 5-10 min warm-up, followed by the exercise; the target heart rate reserve (HRR) range associated with the VO2R range will be maintained for as long as possible during each exercise period. This will be followed by a 5-10 min cool-down.
Group II: Stretching-and-Toning Exercise TrainingActive Control1 Intervention
The active, non-aerobic exercise condition will involve stretching-and-toning activities using the same frequency and duration of the treadmill walking exercise condition. These activities will be based on a manual provided by the National Multiple Sclerosis Society and sessions will be led by trained exercise leaders who are not involved in the collection of outcome assessments. Activities will target the head/neck, shoulder, elbow/forearm, hand/wrist, trunk/hip, ankle/foot. The progression of activities over the 3-month period will involve performing additional exercises and sets along with using progressively thicker elastic resistance bands that provide minimal resistance. Each session is designed to last up to 60 minutes in total. Each session will begin with a warm-up of up to 10 minutes, followed by stretching-and-toning (following the same duration as the treadmill walking exercise training condition) activities, and a cool-down of up to 10 minutes.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,036 Total Patients Enrolled
33 Trials studying Multiple Sclerosis
1,614 Patients Enrolled for Multiple Sclerosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,045 Previous Clinical Trials
2,730,910 Total Patients Enrolled
18 Trials studying Multiple Sclerosis
1,765 Patients Enrolled for Multiple Sclerosis
National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,159,589 Total Patients Enrolled
9 Trials studying Multiple Sclerosis
1,277 Patients Enrolled for Multiple Sclerosis

Media Library

Treadmill Walking Exercise Training Clinical Trial Eligibility Overview. Trial Name: NCT03677440 — N/A
Multiple Sclerosis Research Study Groups: Stretching-and-Toning Exercise Training, Treadmill Walking Exercise Training
Multiple Sclerosis Clinical Trial 2023: Treadmill Walking Exercise Training Highlights & Side Effects. Trial Name: NCT03677440 — N/A
Treadmill Walking Exercise Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03677440 — N/A
~6 spots leftby Nov 2025